These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38587919)

  • 1. Super-enhancers: drivers of cells' identities and cells' debacles.
    Lavaud M; Tesfaye R; Lassous L; Brounais B; Baud'huin M; Verrecchia F; Lamoureux F; Georges S; Ory B
    Epigenomics; 2024 Apr; 16(9):681-700. PubMed ID: 38587919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
    Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Super-Enhancers for Disease Treatment and Diagnosis.
    Shin HY
    Mol Cells; 2018 Jun; 41(6):506-514. PubMed ID: 29754476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
    Khan A; Mathelier A; Zhang X
    Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Master transcription factors and mediator establish super-enhancers at key cell identity genes.
    Whyte WA; Orlando DA; Hnisz D; Abraham BJ; Lin CY; Kagey MH; Rahl PB; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):307-19. PubMed ID: 23582322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying clusters of
    Madani Tonekaboni SA; Mazrooei P; Kofia V; Haibe-Kains B; Lupien M
    Genome Res; 2019 Oct; 29(10):1733-1743. PubMed ID: 31533978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-enhancers in the control of cell identity and disease.
    Hnisz D; Abraham BJ; Lee TI; Lau A; Saint-André V; Sigova AA; Hoke HA; Young RA
    Cell; 2013 Nov; 155(4):934-47. PubMed ID: 24119843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
    Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
    Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-enhancers in transcriptional regulation and genome organization.
    Wang X; Cairns MJ; Yan J
    Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions.
    Wu M; Shen J
    Front Oncol; 2019; 9():1307. PubMed ID: 31824865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primordial super-enhancers: heat shock-induced chromatin organization in yeast.
    Kainth AS; Chowdhary S; Pincus D; Gross DS
    Trends Cell Biol; 2021 Oct; 31(10):801-813. PubMed ID: 34001402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status.
    Vasileva AV; Gladkova MG; Ashniev GA; Osintseva ED; Orlov AV; Kravchuk EV; Boldyreva AV; Burenin AG; Nikitin PI; Orlova NN
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-lncRNAs: identification of lncRNAs that target super-enhancers via RNA:DNA:DNA triplex formation.
    Soibam B
    RNA; 2017 Nov; 23(11):1729-1742. PubMed ID: 28839111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting super-enhancer activity for colorectal cancer therapy.
    Voutsadakis IA
    Am J Transl Res; 2024; 16(3):700-719. PubMed ID: 38586095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
    Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
    Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin interaction networks revealed unique connectivity patterns of broad H3K4me3 domains and super enhancers in 3D chromatin.
    Thibodeau A; Márquez EJ; Shin DG; Vera-Licona P; Ucar D
    Sci Rep; 2017 Oct; 7(1):14466. PubMed ID: 29089515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.